Dermatological side effects of dipeptidyl Peptidase-4 inhibitors in diabetes management: a comprehensive review
Abstract Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of drugs that enhance the incretin-insulin pathway and offer effective glycemic control in type 2 diabetes mellitus. However, these drugs may be associated with various dermatological side effects, ranging from mild to severe. This revie...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-03-01
|
| Series: | Clinical Diabetes and Endocrinology |
| Online Access: | https://doi.org/10.1186/s40842-024-00165-w |